DOSSIER · 13F-HR · Q4 2025

TUCKER ASSET MANAGEMENT LLC

$343M in tracked AUM across 1,080 positions as of Q4 2025.

TA
CIK 0001870012 · last filed Dec 31, 2025
Total AUM
$343M
as of Q4 2025
Holdings
1,080
positions
Whale Score
51
51
tracked
Activity
no data
changes this Q
AI Analysis · Q4 2025
Comprehensive Analysis of SEC 13F Filing: TUCKER ASSET MANAGEMENT LLC
1. Portfolio Overview

Tucker Asset Management LLC manages a portfolio totaling approximately $251.19 million as of the report date September 30, 2025, representing a growth of 4.5% from the previous quarter's $240.41 million. The portfolio is highly diversified in terms of the number of instruments, holding 184 distinct positions, but it exhibits significant concentration regarding asset allocation.

The firm...

2. Key Holdings

The portfolio is dominated by a few massive positions that serve as the portfolio's foundation.

  • Core Equity Exposure: The SPDR S&P 500 ETF Trust (SPY) is the largest holding, comprising 37.34% ($93.80M) of the total portfolio. This massive allocation indicates a strong conviction in the broad U.S. equity market. The Invesco S&P 500 Equal Weight ETF (RSP) is the third-largest holding at 11.63% ($29.21M). The combination of SPY (cap-weighted) and RSP (equal weight) suggests the manager seeks market participation while mitigating the concentration risk inherent in the mega-cap tech stocks that dominate the S&P 500.
  • Liquidity and Fixed Income: The First Trust Exchange-Traded Fund (FTSM) holds the second position at 14.80% ($37.17M). FTSM is a low-duration, actively managed ETF that focuses on cash and cash equivalents. Combined with BIL (SPDR Bloomberg 1-3 Month T-Bill ETF) at 4.74%, the firm holds nearly 20% of the portfolio in very liquid, short-term instruments. This suggests a defensive posture or a "dry powder" strategy ready to be deployed.
  • Significant Equity Bets: NVIDIA (NVDA) is the lone standout single stock in the top tier, representing 7.49% ($18.80M). This is a substantial allocation to a single technology name, implying a strong view on the AI/semiconductor sector. Amneal Pharmaceuticals (AMRX) is also notably concentrated at 4.43% ($11.12M), representing a significant idiosyncratic bet on the healthcare sector.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
SPY
SPDR S&P 500 ETF TR
$98M144K28.7%
02
04609E107
INVESCO QQQ TR
$41M67K12.0%
03
FTSM
FIRST TR EXCHANGE-TRADED FD
$37M616K10.8%
04
RSP
INVESCO EXCHANGE TRADED FD T
$27M140K7.8%
05
NVDA
NVIDIA CORPORATION
$19M101K5.5%
06
AMRX
AMNEAL PHARMACEUTICALS INC
$13M1.0M3.7%
07
BIL
SPDR SERIES TRUST
$7M79K2.1%
08
SHV
ISHARES TR
$6M54K1.7%
09
USHY
ISHARES TR
$4M97K1.1%
10
AAPL
APPLE INC
$3M13K1.0%

Filing history

2025Q4Dec 31
$343M 36.7%
1,080 positionsView →
2025Q3Sep 30
$251M 4.5%
184 positionsView →
2025Q2Jun 30
$240M 2.2%
173 positionsLocked
2025Q1Mar 31
$246M 73.8%
170 positionsLocked
2024Q4Dec 31
$939M 116.8%
1,601 positionsLocked
2024Q3Sep 30
$433M 5.5%
1,483 positionsLocked
2024Q2Jun 30
$458M 5.5%
1,693 positionsLocked
2024Q1Mar 31
$434M 8.4%
1,676 positionsLocked
2023Q4Dec 31
$400M 6.9%
1,490 positionsLocked
2023Q3Sep 30
$374M 8.8%
1,408 positionsLocked
2023Q2Jun 30
$344M 2.9%
1,169 positionsLocked
2023Q1Mar 31
$335M 7.6%
1,191 positionsLocked
Showing 12 of 21